{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada est une publication bilingue et libre d'accès revue par un comité de lecture portant sur la prévention et le contrôle des maladies infectieuses nouvelles et tenaces.","en":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"P1M","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"97e69a0e-76fd-4450-b164-507458be040d","metadata_created":"2020-01-24T18:45:04.399826","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-01-24T18:45:04.399833","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-01-24","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Gestion des antimicrobiens","infection des voies respiratoires","infection des voies urinaires","amélioration de la qualité","soins primaires","soins de longue durée","tuberculose","surveillance","résistance aux antituberculeux","Canada","vaccins","réticence à la vaccination","politique fondée sur des données probantes"],"en":["Antimicrobial resistance","antimicrobial stewardship","respiratory infection","urinary tract infection","quality improvement","primary care","long-term care","tuberculosis","surveillance","drug resistance","Canada","immunization","vaccine hesitancy","evidence-based policy"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"RMTC : Volume 46–01 - le 2 janvier 2020 : Résistance aux antimicrobiens","en":"CCDR: Volume 46–01 - January 2, 2020: Antimicrobial resistance (AMR)"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"2c0995b9-d090-42b1-866d-38cd27724496","related_relationship":"","name_translated":{"fr":"RMTC : Volume 46–01 - le 2 janvier 2020 : Résistance aux antimicrobiens","en":"CCDR: Volume 46–01 - January 2, 2020: Antimicrobial resistance (AMR)"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 46–01 - January 2, 2020: Antimicrobial resistance (AMR)","language":["en"],"created":"2020-01-24T18:45:07.553226","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020.html","last_modified":null,"position":0,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"fcd74a71-afe4-4506-94f0-f0a851e5ceb8","related_relationship":"","name_translated":{"fr":"RMTC : Volume 46–01 - le 2 janvier 2020 : Résistance aux antimicrobiens","en":"CCDR: Volume 46–01 - January 2, 2020: Antimicrobial resistance (AMR)"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 46–01 - January 2, 2020: Antimicrobial resistance (AMR)","language":["fr"],"created":"2020-01-24T18:45:07.553236","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-1-2-janvier-2020.html","last_modified":null,"position":1,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"367391a6-181a-46d6-a2c0-22a4bb866086","related_relationship":"","name_translated":{"fr":"RMTC : Volume 46–01 - le 2 janvier 2020 : Résistance aux antimicrobiens","en":"CCDR: Volume 46–01 - January 2, 2020: Antimicrobial resistance (AMR)"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 46–01 - January 2, 2020: Antimicrobial resistance (AMR)","language":["en"],"created":"2020-01-24T18:45:07.553239","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01-eng.pdf","last_modified":null,"position":2,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"00d96baa-6565-4a0b-a257-3a2a29eebf92","related_relationship":"","name_translated":{"fr":"RMTC : Volume 46–01 - le 2 janvier 2020 : Résistance aux antimicrobiens","en":"CCDR: Volume 46–01 - January 2, 2020: Antimicrobial resistance (AMR)"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 46–01 - January 2, 2020: Antimicrobial resistance (AMR)","language":["fr"],"created":"2020-01-24T18:45:07.553241","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01f-fra.pdf","last_modified":null,"position":3,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b607000d-8f59-4c05-9c59-773e1068061e","related_relationship":"","name_translated":{"fr":"\"Changements des pratiques dirigées par","en":"Prescriber-led practice changes that can bolster antimicrobial stewardship in community health care settings"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Prescriber-led practice changes that can bolster antimicrobial stewardship in community health care settings","language":["en"],"created":"2020-01-24T18:45:07.553243","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/article-1-antimicrobial-stewardship-health-care-settings.html","last_modified":null,"position":4,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"90f0cbb6-c81d-46ee-888b-0185e6d9d921","related_relationship":"","name_translated":{"fr":"\"Changements des pratiques dirigées par","en":"Prescriber-led practice changes that can bolster antimicrobial stewardship in community health care settings"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Prescriber-led practice changes that can bolster antimicrobial stewardship in community health care settings","language":["fr"],"created":"2020-01-24T18:45:07.553246","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-1-2-janvier-2020/article-1-gerance-antimicrobiens-milieux-soins-sante.html","last_modified":null,"position":5,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ce5a08f3-5835-4dea-a2d7-bbcb12ad8cd4","related_relationship":"","name_translated":{"fr":"\"Changements des pratiques dirigées par","en":"Prescriber-led practice changes that can bolster antimicrobial stewardship in community health care settings"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Prescriber-led practice changes that can bolster antimicrobial stewardship in community health care settings","language":["en"],"created":"2020-01-24T18:45:07.553248","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a01-eng.pdf","last_modified":null,"position":6,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4c12bdaa-fc6b-4977-b85d-713738fdf3e3","related_relationship":"","name_translated":{"fr":"\"Changements des pratiques dirigées par","en":"Prescriber-led practice changes that can bolster antimicrobial stewardship in community health care settings"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Prescriber-led practice changes that can bolster antimicrobial stewardship in community health care settings","language":["fr"],"created":"2020-01-24T18:45:07.553250","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a01f-fra.pdf","last_modified":null,"position":7,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"9f6ddc40-90a2-4efa-9033-58ae955468a8","related_relationship":"","name_translated":{"fr":"Système canadien de surveillance de la résistance au antimicrobiens (SCSRA) - Soins de santé","en":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Health Care"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Health Care","language":["en"],"created":"2020-01-24T18:45:07.553253","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/article-1b-antimicrobial-resistance-health-care-settings.html","last_modified":null,"position":8,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ce0ede1d-ebdd-424c-a429-1667bac19e73","related_relationship":"","name_translated":{"fr":"Système canadien de surveillance de la résistance au antimicrobiens (SCSRA) - Soins de santé","en":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Health Care"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Health Care","language":["fr"],"created":"2020-01-24T18:45:07.553255","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-1-2-janvier-2020/article-1b-resistance-antimicrobiens-milieux-soins-sante.html","last_modified":null,"position":9,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"2b59356e-5be9-4c4e-b2d5-9c2709e17c0d","related_relationship":"","name_translated":{"fr":"Système canadien de surveillance de la résistance au antimicrobiens (SCSRA) - Soins de santé","en":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Health Care"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Health Care","language":["en"],"created":"2020-01-24T18:45:07.553257","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a01b-eng.pdf","last_modified":null,"position":10,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"77972afb-9d04-453b-8139-f6e29b4abf56","related_relationship":"","name_translated":{"fr":"Système canadien de surveillance de la résistance au antimicrobiens (SCSRA) - Soins de santé","en":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Health Care"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Health Care","language":["fr"],"created":"2020-01-24T18:45:07.553259","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a01bf-fra.pdf","last_modified":null,"position":11,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"e972cf1e-8249-4584-a170-63146a0671f7","related_relationship":"","name_translated":{"fr":"Système canadien de surveillance de la résistance au antimicrobiens (SCSRA) - Communauté","en":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Community"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Community","language":["en"],"created":"2020-01-24T18:45:07.553261","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/article-1c-antimicrobial-resistance-community-settings.html","last_modified":null,"position":12,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"cfb907b7-fa5f-4266-9a73-d82f0b64344a","related_relationship":"","name_translated":{"fr":"Système canadien de surveillance de la résistance au antimicrobiens (SCSRA) - Communauté","en":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Community"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Community","language":["fr"],"created":"2020-01-24T18:45:07.553263","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-1-2-janvier-2020/article-1c-resistance-antimicrobiens-milieux-communautaires.html","last_modified":null,"position":13,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6c4e2bb7-d19a-46a8-8da5-3df4ca872c20","related_relationship":"","name_translated":{"fr":"Système canadien de surveillance de la résistance au antimicrobiens (SCSRA) - Communauté","en":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Community"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Community","language":["en"],"created":"2020-01-24T18:45:07.553266","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a01c-eng.pdf","last_modified":null,"position":14,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"df923bef-85fb-4b67-af87-a2cc8b13d611","related_relationship":"","name_translated":{"fr":"Système canadien de surveillance de la résistance au antimicrobiens (SCSRA) - Communauté","en":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Community"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Community","language":["fr"],"created":"2020-01-24T18:45:07.553268","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a01cf-fra.pdf","last_modified":null,"position":15,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"8e64a210-a996-4015-a570-6c5ef8f8b553","related_relationship":"","name_translated":{"fr":"Système canadien de surveillance de la résistance au antimicrobiens (SCSRA) - Chaîne alimentaire","en":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Food Chain"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Food Chain","language":["en"],"created":"2020-01-24T18:45:07.553270","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/article-1d-antimicrobial-resistance-food-chain.html","last_modified":null,"position":16,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"74fce5fc-a5c9-4528-9caf-1c42c99ebb18","related_relationship":"","name_translated":{"fr":"Système canadien de surveillance de la résistance au antimicrobiens (SCSRA) - Chaîne alimentaire","en":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Food Chain"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Food Chain","language":["fr"],"created":"2020-01-24T18:45:07.553272","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-1-2-janvier-2020/article-1d-resistance-antimicrobiens-chaine-alimentaire.html","last_modified":null,"position":17,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4f29e45f-b748-45e8-98ac-92e3a24113be","related_relationship":"","name_translated":{"fr":"Système canadien de surveillance de la résistance au antimicrobiens (SCSRA) - Chaîne alimentaire","en":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Food Chain"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Food Chain","language":["en"],"created":"2020-01-24T18:45:07.553274","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a01d-eng.pdf","last_modified":null,"position":18,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"47443a65-8c0a-4291-8da8-dff9db163dcd","related_relationship":"","name_translated":{"fr":"Système canadien de surveillance de la résistance au antimicrobiens (SCSRA) - Chaîne alimentaire","en":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Food Chain"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canadian Antimicrobial Resistance Surveillance System (CARSS) - Food Chain","language":["fr"],"created":"2020-01-24T18:45:07.553276","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a01df-fra.pdf","last_modified":null,"position":19,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"51aea020-357b-4c53-963e-efbf30dbb6a4","related_relationship":"","name_translated":{"fr":"La résistance aux antituberculeux au Canada : 2018","en":"Tuberculosis drug resistance in Canada: 2018"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Tuberculosis drug resistance in Canada: 2018","language":["en"],"created":"2020-01-24T18:45:07.553278","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/article-2-tuberculosis-trend-canada-2008-2018.html","last_modified":null,"position":20,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"43b4d58c-6243-4c7e-99fc-5a1526e00854","related_relationship":"","name_translated":{"fr":"La résistance aux antituberculeux au Canada : 2018","en":"Tuberculosis drug resistance in Canada: 2018"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Tuberculosis drug resistance in Canada: 2018","language":["fr"],"created":"2020-01-24T18:45:07.553281","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-1-2-janvier-2020/article-2-tendance-tuberculose-canada-2008-2018.html","last_modified":null,"position":21,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ac89308d-a259-4aa2-858a-3e5285742fc1","related_relationship":"","name_translated":{"fr":"La résistance aux antituberculeux au Canada : 2018","en":"Tuberculosis drug resistance in Canada: 2018"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Tuberculosis drug resistance in Canada: 2018","language":["en"],"created":"2020-01-24T18:45:07.553283","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a02-eng.pdf","last_modified":null,"position":22,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"7ed885ba-f8b1-4981-910b-bfdb0d462f8d","related_relationship":"","name_translated":{"fr":"La résistance aux antituberculeux au Canada : 2018","en":"Tuberculosis drug resistance in Canada: 2018"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Tuberculosis drug resistance in Canada: 2018","language":["fr"],"created":"2020-01-24T18:45:07.553285","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a02f-fra.pdf","last_modified":null,"position":23,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4daf513c-b5aa-4d04-affe-1e5b1b31ea80","related_relationship":"","name_translated":{"fr":"Le Centre canadien de ressources et d’échange sur les données probantes en vaccination (CANVax) : Une nouvelle ressource permettant de résumer les données probantes sur la vaccination","en":"A new resource to summarize evidence on immunization from the Canadian Vaccination Evidence Resource and Exchange Centre (CANVax)"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"A new resource to summarize evidence on immunization from the Canadian Vaccination Evidence Resource and Exchange Centre (CANVax)","language":["en"],"created":"2020-01-24T18:45:07.553287","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/article-3-canvax-online-resource.html","last_modified":null,"position":24,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"8df9e17d-7e17-49f0-925c-a2a4411730f3","related_relationship":"","name_translated":{"fr":"Le Centre canadien de ressources et d’échange sur les données probantes en vaccination (CANVax) : Une nouvelle ressource permettant de résumer les données probantes sur la vaccination","en":"A new resource to summarize evidence on immunization from the Canadian Vaccination Evidence Resource and Exchange Centre (CANVax)"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"A new resource to summarize evidence on immunization from the Canadian Vaccination Evidence Resource and Exchange Centre (CANVax)","language":["fr"],"created":"2020-01-24T18:45:07.553289","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-1-2-janvier-2020/article-3-canvax-ressource-ligne.html","last_modified":null,"position":25,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"id":"aa1e2f9a-d546-4f3f-a1cf-112542a600bf","character_set":"","state":"active","name_translated":{"fr":"Le Centre canadien de ressources et d’échange sur les données probantes en vaccination (CANVax) : Une nouvelle ressource permettant de résumer les données probantes sur la vaccination","en":"A new resource to summarize evidence on immunization from the Canadian Vaccination Evidence Resource and Exchange Centre (CANVax)"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"A new resource to summarize evidence on immunization from the Canadian Vaccination Evidence Resource and Exchange Centre (CANVax)","language":["en"],"created":"2020-01-24T18:45:07.553291","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a03-eng.pdf","last_modified":null,"position":26,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"5be8b9c2-3f74-43f6-b915-6f4a190c5243","related_relationship":"","name_translated":{"fr":"Le Centre canadien de ressources et d’échange sur les données probantes en vaccination (CANVax) : Une nouvelle ressource permettant de résumer les données probantes sur la vaccination","en":"A new resource to summarize evidence on immunization from the Canadian Vaccination Evidence Resource and Exchange Centre (CANVax)"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"A new resource to summarize evidence on immunization from the Canadian Vaccination Evidence Resource and Exchange Centre (CANVax)","language":["fr"],"created":"2020-01-24T18:45:07.553294","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a03f-fra.pdf","last_modified":null,"position":27,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"a502955b-c58b-4003-adcd-3a83ab7cbe96","related_relationship":"","name_translated":{"fr":"Promouvoir la résilience vaccinale à l’ère de l’information numérique","en":"Promoting immunization resiliency in the digital information age"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Promoting immunization resiliency in the digital information age","language":["en"],"created":"2020-01-24T18:45:07.553296","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/article-4-canvax-promoting-immunization-resiliency.html","last_modified":null,"position":28,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d3430594-204f-4d6b-9e37-ecf9347b19d8","related_relationship":"","name_translated":{"fr":"Promouvoir la résilience vaccinale à l’ère de l’information numérique","en":"Promoting immunization resiliency in the digital information age"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Promoting immunization resiliency in the digital information age","language":["fr"],"created":"2020-01-24T18:45:07.553298","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-1-2-janvier-2020/article-4-canvax-promouvoir-resilience-vaccination.html","last_modified":null,"position":29,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"fc0fe9ba-cb4f-4552-95ca-07f0acc73bdc","related_relationship":"","name_translated":{"fr":"Promouvoir la résilience vaccinale à l’ère de l’information numérique","en":"Promoting immunization resiliency in the digital information age"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Promoting immunization resiliency in the digital information age","language":["en"],"created":"2020-01-24T18:45:07.553300","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a04-eng.pdf","last_modified":null,"position":30,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"0f63a8e4-fb30-402f-83a5-227241975ed0","related_relationship":"","name_translated":{"fr":"Promouvoir la résilience vaccinale à l’ère de l’information numérique","en":"Promoting immunization resiliency in the digital information age"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Promoting immunization resiliency in the digital information age","language":["fr"],"created":"2020-01-24T18:45:07.553302","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a04f-fra.pdf","last_modified":null,"position":31,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"554bf231-61fd-49c1-9152-304cc389a2cd","related_relationship":"","name_translated":{"fr":"Rapport national de mi-saison sur l’influenza au Canada, 2019 à 2020","en":"National Influenza Mid-Season Report, 2019–2020"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"National Influenza Mid-Season Report, 2019–2020","language":["en"],"created":"2020-01-24T18:45:07.553305","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/article-5-canada-national-influenza-season.html","last_modified":null,"position":32,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4b09b2dc-0990-40f3-beb9-a3719c9202e8","related_relationship":"","name_translated":{"fr":"Rapport national de mi-saison sur l’influenza au Canada, 2019 à 2020","en":"National Influenza Mid-Season Report, 2019–2020"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"National Influenza Mid-Season Report, 2019–2020","language":["fr"],"created":"2020-01-24T18:45:07.553307","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-1-2-janvier-2020/article-5-saison-grippe-canada.html","last_modified":null,"position":33,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"54796bcc-3f59-475c-864c-d6e34a81f68f","related_relationship":"","name_translated":{"fr":"Rapport national de mi-saison sur l’influenza au Canada, 2019 à 2020","en":"National Influenza Mid-Season Report, 2019–2020"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"National Influenza Mid-Season Report, 2019–2020","language":["en"],"created":"2020-01-24T18:45:07.553309","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a05-eng.pdf","last_modified":null,"position":34,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1f303aab-1013-4106-8e87-b9257d959632","related_relationship":"","name_translated":{"fr":"Rapport national de mi-saison sur l’influenza au Canada, 2019 à 2020","en":"National Influenza Mid-Season Report, 2019–2020"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"National Influenza Mid-Season Report, 2019–2020","language":["fr"],"created":"2020-01-24T18:45:07.553311","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a05f-fra.pdf","last_modified":null,"position":35,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"678b8738-6e87-4bb3-9998-54d329bf994d","related_relationship":"","name_translated":{"fr":"Renseignements pour les auteurs : 2020","en":"Information for authors, 2020"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Information for authors, 2020","language":["en"],"created":"2020-01-24T18:45:07.553313","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/article-6-information-authors.html","last_modified":null,"position":36,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"96818a1a-7be3-4d44-9712-e9b7f04ab84d","related_relationship":"","name_translated":{"fr":"Renseignements pour les auteurs : 2020","en":"Information for authors, 2020"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Information for authors, 2020","language":["fr"],"created":"2020-01-24T18:45:07.553316","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-1-2-janvier-2020/article-6-auteurs-information.html","last_modified":null,"position":37,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"34b25cba-034b-4352-aa84-d595b70f435f","related_relationship":"","name_translated":{"fr":"Renseignements pour les auteurs : 2020","en":"Information for authors, 2020"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Information for authors, 2020","language":["en"],"created":"2020-01-24T18:45:07.553318","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a06-eng.pdf","last_modified":null,"position":38,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"f6259c73-86eb-4692-971f-304c85485ad6","related_relationship":"","name_translated":{"fr":"Renseignements pour les auteurs : 2020","en":"Information for authors, 2020"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Information for authors, 2020","language":["fr"],"created":"2020-01-24T18:45:07.553320","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a06f-fra.pdf","last_modified":null,"position":39,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d7528faf-13b9-4de3-8152-d4d789d85501","related_relationship":"","name_translated":{"fr":"Actualités sur les maladies infectieuses","en":"Testing for Sexually Transmitted Infections in schools; CDC Report"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Testing for Sexually Transmitted Infections in schools; CDC Report","language":["en"],"created":"2020-01-24T18:45:07.553322","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/article-7-id-news.html","last_modified":null,"position":40,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b413c536-ca4d-4e12-bc13-900a8c7be780","related_relationship":"","name_translated":{"fr":"Actualités sur les maladies infectieuses","en":"Testing for Sexually Transmitted Infections in schools; CDC Report"},"hash":"","description":"","format":"HTML","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Testing for Sexually Transmitted Infections in schools; CDC Report","language":["fr"],"created":"2020-01-24T18:45:07.553324","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-1-2-janvier-2020/article-7-actualites-maladies-infectieuses.html","last_modified":null,"position":41,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"3de516ef-d7a4-4acd-a790-65395b2e8ca9","related_relationship":"","name_translated":{"fr":"Actualités sur les maladies infectieuses","en":"Testing for Sexually Transmitted Infections in schools; CDC Report"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Testing for Sexually Transmitted Infections in schools; CDC Report","language":["en"],"created":"2020-01-24T18:45:07.553327","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a07-eng.pdf","last_modified":null,"position":42,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"97e69a0e-76fd-4450-b164-507458be040d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1793f0b4-fc69-403e-87f7-aa30fe11159a","related_relationship":"","name_translated":{"fr":"Actualités sur les maladies infectieuses","en":"Testing for Sexually Transmitted Infections in schools; CDC Report"},"hash":"","description":"","format":"PDF","date_published":"2020-01-02","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Testing for Sexually Transmitted Infections in schools; CDC Report","language":["fr"],"created":"2020-01-24T18:45:07.553329","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/ccdrv46i01a07f-fra.pdf","last_modified":null,"position":43,"revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df","resource_type":"website"}],"place_of_publication":[],"num_resources":44,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2020-01-02 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"97e69a0e-76fd-4450-b164-507458be040d","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR: Volume 46–01 - January 2, 2020: Antimicrobial resistance (AMR)","revision_id":"09388f11-b88b-44b3-86e1-f87b70bf20df"}